Affinity Asset Advisors’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-16,667
Closed -$1.9M – 82
2020
Q4
$1.9M Buy
+16,667
New +$1.05M 1% 30

Other funds holding SLDB

Affinity Asset Advisors's SLDB Position: Q3 2026 in Review

Affinity Asset Advisors opened a new position in Solid Biosciences (SLDB) in Q3 2026: 400,000 shares worth $2.89M. The stake represents 0.12% of the portfolio and ranks #102 among its holdings.

158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • Affinity Asset Advisors held 400,000 shares of Solid Biosciences worth $2.89M as of Q3 2026.
  • Solid Biosciences was a new Affinity Asset Advisors position in Q3 2026.
  • Solid Biosciences made up 0.12% of Affinity Asset Advisors's portfolio in Q3 2026, its #102 holding.
  • 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.